Some of the neurological and psychiatric complications associated with HIV may be side effects of the medications that control the virus, and not caused by the virus itself, according to a new study from researchers at The Children’s Hospital of Philadelphia and the University of Pennsylvania.
Recent data has shown that AIDS-related mortality declined from 2005 to 2012 for adults and children, adolescent mortality has increased by 50 percent. What is creating such a huge equity gap in treatment for adolescents?
A Children’s Hospital of Philadelphia pediatrician’s research projects span across continents to Botswana, a sub-Saharan African country with a busy clinic for 2,000 HIV-infected children and adolescents who stole her heart.
A large-scale study of two first-line treatments for HIV-infected children shows that the less-used regimen is more effective in suppressing the virus, paving the way for changing the standard of care provided to infected children in sub-Saharan Africa, where the virus is most prevalent.
Researchers from The Children's Hospital of Philadelphia and the Perelman School of Medicine at The University of
The Grinspan Lab focuses on oligodendrocytes, cells of the central nervous system that synthesize the myelin sheath required for transmission of nervous impulses. Failure of myelination results in motor and cognitive deficits. The lab’s studies seek to understand the signaling pathways that regulate oligodendrocyte maturation and how they are perturbed in diseases such as multiple sclerosis, HIV, and perinatal white matter injury.